CLINICAL_TRIALS
trial_result
· 2023-01-26
Clinical Trial Update: To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa [Phase 2]
Summary
This Phase 2 trial evaluating INCB054707 in hidradenitis suppurativa (acne inversa) completed and results were posted in January 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Status: COMPLETED | Results posted: 2023-01-26